Berman Robert Andrew
- SEC CIK
- 0001258360
No open-market purchases or sales filed in the past year.
Current role at each company
- NVNO enVVeno Medical CorpChief Executive Officeras of Dec 18, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Berman Robert Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2024 (view filing) | Dec 19 | Same day | Berman Robert AndrewChief Executive Officer | PPurchase | +12.0K | $2.55 | +$30.6K | +5.7%222.2K after | |
| Jun 28, 2022 (view filing) | Jun 27 | 1 day | Berman Robert AndrewChief Executive Officer | PPurchase | +2.50K | $3.80 | +$9.50K | +1.2%210.2K after | |
| Nov 19, 2021 (view filing) | Nov 19 | Same day | Berman Robert AndrewCEO | PPurchase | +2.00K | $7.43 | +$14.9K | +34.9%7.74K after | |
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Berman Robert AndrewCEO | PPurchase | +2.00K | $7.87 | +$15.7K | +53.5%5.74K after |